Twitter

Archive for August 9th, 2012


ASCO 2012: Prostate Cancer

Dr. Charles J. Ryan of the University of California, San Francisco, joins Dr. Walter M. Stadler, associate editor of The Oncology Report, in a discussion of leading prostate cancer research at the 2012 annual meeting of the American Society of Clinical Oncology. Topics include the pivotal abiraterone trial results presented by Dr. Ryan, novel androgen inhibitors, the role of prednisone, and the controversial conclusions of the largest and longest study comparing intermittent with continuous androgen deprivation therapy.

Read More...

No Proven Benefit For PET And PET/CT In Ovarian Cancer

Only in certain cases are recurrences detected more reliably than with conventional techniques Due to the lack of studies, there is currently no proof that patients with ovarian cancer can benefit from positron emission tomography (PET) alone or in combination with computed tomography (CT)…

Read More...

NGPDT – Cancer Treatment Hospital Tour

Scott Waters (Operations Manager) presents one of NGPDT’s cancer patient treatment hospitals. NGPDT provides top facilities for in or out patient care, aswell as the latest diagnostics equipment to compliment our NGPDT proprietary cancer treatment protocols. www.NextGenerationPDT.com www.NGPDT.com

Read More...

Area businesses, friends and family pitch in to help out Angela Kirkland

An Amarillo family needs some help after the young mother is diagnosed with a brain tumor. Amarillo businesses pitch in give a helping hand.

Read More...

New drug improves prognosis in advanced breast cancer cases

A recent drug approval by the U.S. Food and Drug Administration is making waves in the breast cancer community.

Read More...

Girl fighting cancer makes inspirational videos

Talia Joy Castellano’s makeup tutorials on YouTube don’t hide the fact that cancer treatments have left her bald.

Read More...

University of Chicago study finds grapefruit juice lets patients take lower dose of cancer drug

A glass a day of grapefruit juice lets patients derive the same benefits from an anti-cancer drug as they would get from more than three times as much of the drug by itself, according to a new clinical trial. The combination could help patients avoid side effects associated with high doses of the drug and reduce the cost of the medication. In a study from University of Chicago Medicine (home to the University of Chicago Comprehensive Cancer Center) published in August in Clinical Cancer Research, researchers show that eight ounces a day of grapefruit juice can slow the body’s metabolism of a drug called sirolimus, which has been approved for transplant patients but may also help many people with cancer.

Read More...

New Guide Provides Patients With Information About Reflux Disease And Its Connection To Barrett’s Esophagus And Esophageal Cancer

Every day, an estimated 25 million American adults suffer from heartburn. Some experts believe that 40 percent of adults experience heartburn every month. Despite these staggering statistics, few people understand the real risk that Heartburn can cause Cancer…

Read More...

Trials Of New Targeted Cancer Drugs Reveal Lower Risk Of Serious Side-Effects

Patients in early clinical trials of new-style targeted cancer therapies appear to have a much lower risk of the most serious side-effects than with traditional chemotherapy, according to a new analysis. Researchers at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust analysed data from 36 Phase I trials run by the organisations’ joint Drug Development Unit…

Read More...

Lower Dose Of Cancer Drug Needed When Grapefruit Juice Prescribed

A glass a day of grapefruit juice lets patients derive the same benefits from an anti-cancer drug as they would get from more than three times as much of the drug by itself, according to a new clinical trial. The combination could help patients avoid side effects associated with high doses of the drug and reduce the cost of the medication…

Read More...